Safety, Regulatory, and Laboratory Operations
Chemical and biological safety
The IHC laboratory handles formalin (a known carcinogen and sensitizer), xylene and other aromatic solvents, DAB (a suspected carcinogen), hydrogen peroxide, and concentrated acids and bases. Requirements include a functioning chemical fume hood, appropriate gloves and eye protection, spill kits, and segregated waste streams for formalin and solvent. Formalin and xylene waste cannot go down the drain; DAB-containing waste and contaminated materials need defined disposal procedures. Universal precautions, sharps handling, and a documented chemical hygiene plan apply. Refer to Safety Data Sheets for first aid and incompatibilities.
Regulatory framework
In the United States, clinical laboratories operate under CLIA '88 with accreditation often through CAP, which publishes checklists covering validation, QC, proficiency testing, personnel competency, and document control. In vitro diagnostic antibodies are FDA-cleared or approved; analyte-specific reagents and research-use-only reagents require laboratory-developed test validation before clinical use. Laboratories must maintain procedure manuals, reagent lot records, equipment maintenance logs, and records of corrective action. Proficiency testing and alternative performance assessment are mandatory for regulated analytes; failure triggers root-cause analysis.
Operations
Good operations include defined standard operating procedures, temperature monitoring for refrigerators and water baths, reagent expiration tracking, inventory control, backup instruments, and a documented chain of custody for specimens. Turnaround time and workload balancing matter, but never at the expense of control performance.
Traps in questions
Mixing formalin and solvent waste streams, assuming a fume hood is optional for xylene, or treating RUO antibodies as ready for clinical reporting are all common wrong answers. So is assuming CAP accreditation eliminates the need for local validation.
Rule of thumb
If a reagent is hazardous, its waste is hazardous too; if an antibody is not FDA-cleared for the intended use, local validation is required before reporting.